This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/drugbank/drug/DB02850/identifier/pdb/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02850/identifier/pubchem-compound/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB02850/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB02850/identifier/drugbank/

Statements

Subject Item
n2:DB02850
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB02850 n11:DB02850
dcterms:title
(1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone
adms:identifier
n6:DB02850 n10:46508138 n12:869 n13:5287556
n3:IUPAC-Name
n4:271B5E9B-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5EA1-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5EA0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5E9D-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5E9E-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5E9F-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5E99-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5E97-363D-11E5-9242-09173F13E4C5 n4:271B5E9A-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5E98-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5EA7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5EA8-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5EA2-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5EA3-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5EA5-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5EA4-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5EA6-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5EAD-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5EAF-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5EB0-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5EAC-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5EAB-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5EAE-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5E9C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5EA9-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5EAA-363D-11E5-9242-09173F13E4C5